Aarti Pharmalabs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

414.82

373.03

356.14

358.14

374.27

Operating profit

107.33

88.27

73.81

76.74

76.79

Interest

4.42

4.10

3.82

4.03

5.80

Gross profit

108.60

84.37

69.99

77.57

70.99

EPS (Rs)

6.95

5.32

4.61

5.26

4.41

Other income

5.69

0.20

-

4.86

-

Stock adjustment

7.36

-5.32

-6.11

-19.29

-8.70

Raw material

179.69

191.11

196.88

193.64

210.12

Power and fuel

-

-

-

-

-

Employee expenses

34.67

34.29

29.84

31.53

30.94

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

85.77

64.68

61.72

75.52

65.12

Provisions made

-

-

-

-

-

Depreciation

17.32

16.94

16.32

15.44

14.25

Taxation

28.26

19.25

11.86

14.50

16.75

Net profit / loss

63.02

48.19

41.81

47.63

39.99

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

45.31

45.31

45.31

45.31

45.31

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

25.87

23.66

20.72

21.43

20.52

GPM (%)

25.83

22.61

-

21.37

-

NPM (%)

14.99

12.91

-

13.12

-